https://ir.tuhurabio.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/_0b4577ffa47b2b3b138998038d9a2607/tuhurabio/files/theme/images/logo-sm.png Equisolve Investor Relations Suite https://ir.tuhurabio.com/news-events/press-releases/detail/45/tuhura-biosciences-reports-first-quarter-2026-financial-results-and-provides-a-corporate-update Fri, 15 May 26 17:00:00 -0400 https://ir.tuhurabio.com/news-events/press-releases/detail/45/tuhura-biosciences-reports-first-quarter-2026-financial-results-and-provides-a-corporate-update https://ir.tuhurabio.com/news-events/press-releases/detail/44/tuhura-biosciences-to-present-at-the-4th-annual-h-c-wainwright-bioconnect-investor-conference Tue, 12 May 26 07:30:00 -0400 https://ir.tuhurabio.com/news-events/press-releases/detail/44/tuhura-biosciences-to-present-at-the-4th-annual-h-c-wainwright-bioconnect-investor-conference https://ir.tuhurabio.com/news-events/press-releases/detail/43/tuhura-biosciences-announces-50-million-credit-facility-and-royalty-transaction-extending-anticipated-cash-runway-into-2028 Wed, 22 Apr 26 07:30:00 -0400 https://ir.tuhurabio.com/news-events/press-releases/detail/43/tuhura-biosciences-announces-50-million-credit-facility-and-royalty-transaction-extending-anticipated-cash-runway-into-2028 https://ir.tuhurabio.com/news-events/press-releases/detail/42/tuhura-biosciences-appoints-amanda-garofalo-mshs-as-senior-vice-president-of-clinical-operations Tue, 07 Apr 26 07:45:00 -0400 https://ir.tuhurabio.com/news-events/press-releases/detail/42/tuhura-biosciences-appoints-amanda-garofalo-mshs-as-senior-vice-president-of-clinical-operations https://ir.tuhurabio.com/news-events/press-releases/detail/41/tuhura-biosciences-reports-fourth-quarter-and-full-year-2025-financial-results-and-provides-a-corporate-update Wed, 01 Apr 26 07:45:00 -0400 https://ir.tuhurabio.com/news-events/press-releases/detail/41/tuhura-biosciences-reports-fourth-quarter-and-full-year-2025-financial-results-and-provides-a-corporate-update https://ir.tuhurabio.com/news-events/press-releases/detail/40/craig-tendler-m-d-jnjs-former-global-head-of-oncology-clinical-development-to-lead-tuhura-biosciences-vista-program-in-aml-and-other-blood-related-cancers Mon, 23 Mar 26 07:45:00 -0400 https://ir.tuhurabio.com/news-events/press-releases/detail/40/craig-tendler-m-d-jnjs-former-global-head-of-oncology-clinical-development-to-lead-tuhura-biosciences-vista-program-in-aml-and-other-blood-related-cancers https://ir.tuhurabio.com/news-events/press-releases/detail/39/tuhura-biosciences-regains-compliance-with-nasdaq-minimum-bid-price-requirement Fri, 27 Feb 26 07:30:00 -0500 https://ir.tuhurabio.com/news-events/press-releases/detail/39/tuhura-biosciences-regains-compliance-with-nasdaq-minimum-bid-price-requirement https://ir.tuhurabio.com/news-events/press-releases/detail/38/tuhura-biosciences-announces-participation-in-upcoming-investor-conferences Tue, 24 Feb 26 17:20:00 -0500 https://ir.tuhurabio.com/news-events/press-releases/detail/38/tuhura-biosciences-announces-participation-in-upcoming-investor-conferences https://ir.tuhurabio.com/news-events/press-releases/detail/37/tuhura-files-investigational-new-drug-application-for-tbs-2025-in-the-treatment-of-blood-related-cancers Tue, 17 Feb 26 07:45:00 -0500 https://ir.tuhurabio.com/news-events/press-releases/detail/37/tuhura-files-investigational-new-drug-application-for-tbs-2025-in-the-treatment-of-blood-related-cancers https://ir.tuhurabio.com/news-events/press-releases/detail/36/tuhura-biosciences-to-present-at-the-oppenheimer-36th-annual-healthcare-life-sciences-conference Thu, 12 Feb 26 07:45:00 -0500 https://ir.tuhurabio.com/news-events/press-releases/detail/36/tuhura-biosciences-to-present-at-the-oppenheimer-36th-annual-healthcare-life-sciences-conference